PANews June 20 news, according to PR Newswire, Parataxis Holdings, a Bitcoin-focused investment startup, announced that it has reached a final agreement with Bridge Biotherapeutics, Inc. to invest 25 billionPANews June 20 news, according to PR Newswire, Parataxis Holdings, a Bitcoin-focused investment startup, announced that it has reached a final agreement with Bridge Biotherapeutics, Inc. to invest 25 billion

Parataxis Holdings to launch Bitcoin asset management platform in South Korea through $18.29 million acquisition

2025/06/20 20:21

PANews June 20 news, according to PR Newswire, Parataxis Holdings, a Bitcoin-focused investment startup, announced that it has reached a final agreement with Bridge Biotherapeutics, Inc. to invest 25 billion won (about 18.29 million U.S. dollars) to enable Parataxis Holdings to obtain a controlling stake in the company. After the completion of this transaction, the company intends to change its name to Parataxis Korea and continue to be listed on the Korean Kosdaq (KOSDAQ). This transaction will create a native Bitcoin-based fund management platform in the Korean open market, which is supported by institutional investors with extensive experience in digital asset investments.

Earlier news said that Parataxis Holdings plans to go public through a SPAC transaction , and the transaction still needs to complete routine procedures such as due diligence, signing a final agreement and obtaining regulatory approval.

Piyasa Fırsatı
Startup Logosu
Startup Fiyatı(STARTUP)
$0.0003338
$0.0003338$0.0003338
-7.17%
USD
Startup (STARTUP) Canlı Fiyat Grafiği
Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen [email protected] ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.